Published December 2012
| Version v1
Journal article
Conducting radiogenomic research – Do not forget careful consideration of the clinical data
Creators
- 1. Aarhus University Hospital (Denmark)
- 2. University of Cambridge (United Kingdom)
- 3. Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen (Netherlands)
- 4. UZ Leuven (Belgium)
- 5. Technische Universität Dresden (Germany)
- 6. University of Wisconsin, Madison (United States)
- 7. The Institute of Cancer Research – Clinical Trials and Statistics Unit (ICR-CTSU), Sutton (United Kingdom)
- 8. Dr. Bernard Verbeeten Instituut, Tilburg (Netherlands)
- 9. Institute of Cancer Research, Sutton (United Kingdom)
Description
The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.radonc.2012.11.004Additional details
Identifiers
- DOI
- 10.1016/j.radonc.2012.11.004;
- PII
- S0167-8140(12)00494-X;
Publishing Information
- Journal Title
- Radiotherapy and Oncology
- Journal Volume
- 105
- Journal Issue
- 3
- Journal Page Range
- p. 337-340
- ISSN
- 0167-8140
- CODEN
- RAONDT
INIS
- Country of Publication
- Ireland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 44102244
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- COOPERATION; DOSIMETRY; GENES; NUCLEOTIDES; RADIOSENSITIVITY
- Descriptors DEC
- ORGANIC COMPOUNDS; SENSITIVITY
Optional Information
- Copyright
- Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.